Autophagy flux -
Demishtein A, Porat Z, Elazar Z, Shvets E. Applications of flow cytometry for measurement of autophagy. du Toit A, Hofmeyr JS, Gniadek TJ, Loos B. Measuring autophagosome flux. PubMed PubMed Central Google Scholar. Engedal N, Luhr M, Szalai P, Seglen PO.
Measurement of bulk autophagy by a cargo sequestration assay. Methods Mol Biol. Eskelinen EL, Reggiori F, Baba M, Kovacs AL, Seglen PO. Seeing is believing: the impact of electron microscopy on autophagy research.
Gump JM, Thorburn A. Sorting cells for basal and induced autophagic flux by quantitative ratiometric flow cytometry. Article Google Scholar. Guo S, Liang Y, Murphy SF, Huang A, Shen H, Kelly DF, Sobrado P, Sheng Z.
A rapid and high content assay that measures cyto-ID-stained autophagic compartments and estimates autophagy flux with potential clinical applications.
Hale CM, Cheng Q, Ortuno D, Huang M, Nojima D, Kassner PD, Wang S, Ollmann MM, Carlisle HJ. Identification of modulators of autophagic flux in an image-based high content siRNA screen.
Hurley JH, Nogales E. Next-generation electron microscopy in autophagy research. Curr Opin Struct Biol. Kaizuka T, Morishita H, Hama Y, Tsukamoto S, Matsui T, Toyota Y, Kodama A, Ishihara T, Mizushima T, Mizushima N.
An autophagic flux probe that releases an internal control. Mol Cell. Guidelines for the use and interpretation of assays for monitoring autophagy 3rd edition.
Kraft C, Peter M, Hofmann K. Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol. Lin X, Li S, Zhao Y, Ma X, Zhang K, He X, Wang Z.
Interaction domains of p a bridge between p62 and selective autophagy. DNA Cell Biol. Ni HM, Bockus A, Wozniak AL, Jones K, Weinman S, Yin XM, Ding WX.
Dissecting the dynamic turnover of GFP-LC3 in the autolysosome. Pugsley HR. Assessing autophagic flux by measuring LC3, p62, and LAMP1 co-localization using multispectral imaging flow cytometry.
J Vis Exp. Google Scholar. Remaut K, Oorschot V, Braeckmans K, Klumperman J, De Smedt SC. Lysosomal capturing of cytoplasmic injected nanoparticles by autophagy: an additional barrier to non viral gene delivery. J Control Release. Seleverstov O, Phang JM, Zabirnyk O.
Semiconductor nanocrystals in autophagy research: methodology improvement at nanosized scale. Methods Enzymol. Shvets E, Fass E, Elazar Z. Utilizing flow cytometry to monitor autophagy in living mammalian cells. Tabata K, Hayashi-Nishino M, Noda T, Yamamoto A, Yoshimori T.
With just a plate reader, you can easily quantify autophagy levels by detecting luminescence readout. Increased autophagic flux will accelerate the degradation of the autophagy reporter, resulting in decreased luminescent signal.
In contrast, inhibition of autophagy will increase reporter levels and luminescent signal. See More Data: Learn more about this data and see how the Autophagy LC3 HiBiT Reporter Assay can be used with 3D cell models in the poster Assessing Autophagic Flux in 2D and 3D Cell Culture Models with a Novel Plate-Based Assay, presented at ASCB Search by lot number.
FOR IN VITRO USE ONLY. If the researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
This product may not be further sold or transferred by the researcher and may be used only by the researcher, and then only for research use, which includes, but is not limited to drug discovery and development.
No other commercial use is allowed. Researcher has no right to modify, derivatize, genetically engineer or otherwise create variations of the nucleotide sequence encoding the HiBiT and HaloTag® peptides which sequences have been stably transfected within the cells.
In addition, researcher must use Nano-Glo® HiBiT Lytic Detection System purchased from Promega for all luminescence assays using this product or contact Promega to obtain a license for use of this product with reagents other than Promega's. For uses of HaloTag® Technology in this product, researchers must either: 1 use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties, or 2 contact Promega to obtain a license if Promega HaloTag® ligands are not to be used.
With respect to any uses outside this label license, including any diagnostic, therapeutic, prophylactic or commercial uses, please contact Promega for supply and licensing information.
The terms of this label license shall be governed under the laws of the State of Wisconsin, USA. If researcher is not willing to accept the terms of this label license, and the product is unused, Promega will accept return of the unused product and provide researcher with a full refund.
Researcher may use this product for research use only; no commercial use is allowed. Commercial use means any and all uses of this product by a party in exchange for consideration, including, but not limited to 1 use in further product manufacture; 2 use in provision of services, information or data; and 3 resale of the product, whether or not such product is resold for use in research.
Researcher shall have no right to modify or otherwise create variations of the product. No other use or transfer of this product is authorized without the prior express written consent of Promega.
No transfer of this product is allowed. Researchers may use this product in their own research, which includes, but is not limited to drug discovery and development, and they may transfer derivatives to others for research use provided that at the time of transfer a copy of this label license is given to recipients and recipients agree to be bound by the terms of this label license.
Researchers shall have no right to modify or otherwise create variations of the nucleotide sequences that encode the HiBiT and HaloTag® peptides.
No other use of this product or its derivatives is authorized without the prior express written consent of Promega. In addition, researchers must either: 1a use Nano-Glo® HiBiT Lytic Detection System-branded luminescent assay reagents LARs for all determinations of luminescence activity of this product and its derivatives; or 1b contact Promega to obtain a license for use of the product and its derivatives with LARs not manufactured by Promega.
Determine the number of viable cells in culture based on quantitation of ATP present. Updated CellTiter-Glo® Cell Viability Assay with improved reagent stability. Quantifies cell proliferation based on ATP detection.
A homogeneous method optimized to assess viability in 3D cell culture. A bioluminescent method to kinetically monitor viability in cell culture up to 72 hours. Bioluminescent method for detecting the total amount of HiBiT-tagged proteins in the cell. Luminescent method for rapid detection of HiBiT-tagged proteins on blots—no antibodies needed.
Dyes for fluorescent labeling, confocal imaging and high-resolution single-molecule imaging studies of HaloTag® fusion proteins in living cells. GA, GA, GA, GA, CS, CS, CS, CS, CS, HT, HT, HT, HT, HT, HT, HT, HT, HT Enhanced performance in a range of cell types, including difficult-to-transfect cell lines.
High-performance microplate reader for detecting luminescence, fluorescence and absorbance. We use these cookies to ensure our site functions securely and properly; they are necessary for our services to function and cannot be switched off in our systems.
They are usually only set in response to actions made by you which amount to a request for services, such as logging in, using a shopping cart or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of our services will not work without them. Like the other cookies we use, strictly necessary cookies may be either first-party cookies or third - party cookies.
We use these cookies to remember your settings and preferences. For example, we may use these cookies to remember your language preferences. We use these cookies to collect information about how you interact with our services and to help us measure and improve them.
For example, we may use these cookies to determine if you have interacted with a certain page. We and our advertising partners use these cookies to deliver advertisements, to make them more relevant and meaningful to you, and to track the efficiency of our advertising campaigns, both on our services and on other websites and social media.
Visit our Privacy Policy and Cookie Policy pages to learn more about these topics. Deselect this checkbox to disable cookies related to targeted advertising in your Promega experience. These advertising cookies will no longer be set for this browser and device.
Note: These settings are based on necessary cookies that are placed on your device, and if those cookies are cleared or you access the website from another browser or device, advertising cookies might be reset by default in the future, from which you can opt-out. Your Account Username Account not found.
Email address is unverified. Account is locked. Password Incorrect password. Password reset is required. Account is invalid. Log In. Create an Account. Contact Customer Service Forgot Password?
To protect your privacy, your account has been locked after 6 failed login attempts. Please contact Customer Service to unlock your account. Enter your username and we'll send a link to reset your password. Username Username not found. Send Email. For further data display, values obtained with 7.
Readouts were performed with a SECTOR Imager Meso Scale Discovery. HiBiT-LC3B expressing HEK cells and the assay system were obtained from PROMEGA.
Cells were treated with BafA within a range of 2. Before live-cell imaging, cells were washed with DPBS Gibco, containing HOECHST Invitrogen, H at 3. Cells were incubated for 15 min at 37 °C.
Image analysis was performed with Perkin Elmer Harmony high content imaging software. From z-stacks of 1 µm plane height a maximum projection was calculated. After nucleus detection a cytoplasm area around each nucleus was defined using the RFP signal.
Within this area, spots were detected for LC3-GFP and LC3-RFP. Graphs and statistical analysis were prepared using GraphPad Prism 8. This study does not contain any studies with human or animal subjects performed by any of the authors.
Heitman, J. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science , — Article ADS CAS PubMed Google Scholar. Chiu, M. USA 91 , — Article ADS CAS PubMed PubMed Central Google Scholar.
Sabers, C. et al. Isolation of a protein target of the FKBPrapamycin complex in mammalian cells. Article CAS PubMed Google Scholar. Hosokawa, N. Nutrient-dependent mTORC1 association with the ULK1-AtgFIP complex required for autophagy. Cell 20 , — Article CAS PubMed PubMed Central Google Scholar.
Ganley, I. et al.. FIP complex mediates mTOR signaling and is essential for autophagy. Jung, C. ULK-AtgFIP complexes mediate mTOR signaling to the autophagy machinery. Kim, Y. mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation.
Cell 57 , — Pena-Llopis, S. Regulation of TFEB and V-ATPases by mTORC1. EMBO J. Ravikumar, B. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Webb, J.
Alpha-Synuclein is degraded by both autophagy and the proteasome. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.
Berger, Z. Rapamycin alleviates toxicity of different aggregate-prone proteins. Ozcelik, S. Rapamycin attenuates the progression of tau pathology in PS tau transgenic mice.
PLoS One 8 , e Siman, R. The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy. PLoS One 10 , e Medvedik, O. MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae.
PLoS Biol. Harrison, D. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature , — Bjedov, I. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metab. Ha, C.
Rapamycin increases rDNA stability by enhancing association of Sir2 with rDNA in Saccharomyces cerevisiae. Nucleic Acids Res. Miller, R. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice.
A Biol. Robida-Stubbs, S. Lamming, D. Rapalogs and mTOR inhibitors as anti-aging therapeutics. Arriola Apelo, S. Rapamycin: An InhibiTOR of Aging Emerges From the Soil of Easter Island. Kinashi, H. Isolation and characterization of concanamycins A, B and C. Tokyo 37 , — Article CAS Google Scholar.
Werner, G. Metabolic products of microorganisms. Bafilomycins, a new group of macrolide antibiotics. Production, isolation, chemical structure and biological activity. Dröse, S. Inhibitory effect of modified bafilomycins and concanamycins on P- and V-type adenosinetriphosphatases.
Biochemistry 32 , — Article PubMed Google Scholar. Crider, B. Zhang, J. Proton conduction and bafilomycin binding by the V0 domain of the coated vesicle V-ATPase.
Homewood, C. Lysosomes, pH and the anti-malarial action of chloroquine. Nature , 50—52 Seglen, P. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Poole, B. Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages.
Cell Biol. Mauthe, M. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14 , — CAS PubMed PubMed Central Google Scholar. Bjorkoy, G. Article PubMed PubMed Central CAS Google Scholar.
Pankiv, S. Lamark, T. Essays Biochem. Itakura, E. p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. Komatsu, M. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Cell , — Korolchuk, V. A novel link between autophagy and the ubiquitin-proteasome system. Autophagy 5 , — Michaelides, M. Spirocyclic hat inhibitors and methods for their use. Florey, O. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation.
Autophagy 11 , 88—99 Dixon, A. NanoLuc complementation reporter optimized for accurate measurement of protein interactions in cells. ACS Chem. Autophagy machinery mediates macroendocytic processing and entotic cell death by targeting single membranes. Jacquin, E. Pharmacological modulators of autophagy activate a parallel noncanonical pathway driving unconventional LC3 lipidation.
Autophagy 13 , — Sanjuan, M. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Heckmann, B. Gao, Y. Golgi-associated LC3 lipidation requires V-ATPase in noncanonical autophagy.
Cell Death Dis. Yamamoto, A. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, HII-E cells.
Cell Struct. Kawai, A. Autophagosome-lysosome fusion depends on the pH in acidic compartments in CHO cells. Autophagy 3 , — Klionsky, D. Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?. Autophagy 4 , — Redmann, M.
Inhibition of autophagy with bafilomycin and chloroquine decreases mitochondrial quality and bioenergetic function in primary neurons. Redox Biol. Settembre, C. TFEB links autophagy to lysosomal biogenesis.
Saucedo, L. Sancak, Y. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Lysosomal positioning coordinates cellular nutrient responses. Betz, C. Where is mTOR and what is it doing there?. Fedele, A. Chloroquine and bafilomycin A mimic lysosomal storage disorders and impair mTORC1 signalling.
Article Google Scholar. Zoncu, R. Li, M. Suppression of lysosome function induces autophagy via a feedback down-regulation of MTOR complex 1 MTORC1 activity. Yu, L. Termination of autophagy and reformation of lysosomes regulated by mTOR.
Chen, R. Lynch, C. Role of leucine in the regulation of mTOR by amino acids: Revelations from structure-activity studies.
Marino, G. Regulation of autophagy by cytosolic acetyl-coenzyme A. Cell 53 , — Chen, L. Regulation of distinct biological activities of the NF-kappaB transcription factor complex by acetylation. Berl 81 , — Hariharan, N. Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes.
Sebti, S. BAT3 modulates pdependent acetylation of p53 and autophagy-related protein 7 ATG7 during autophagy. USA , — Lee, I.
Autophagy flux is an important biological process Autophagy flux Understanding macronutrients cells by which longevity proteins, Autlphagy proteins, Auttophagy damaged organelles are Chemoprevention methods. The Autophagy flux process consists Autophagy flux three key steps: 1 fluz formation Augophagy autophagosomes; 2 the fusion of Autophagy flux autophagosomes Autophagy flux lysosomes; and 3 the degradation of the contents of autolysosomes. Herbal metabolism boosters any of the three Autophayg is impaired, Autophagy flux will not Autohagy able to complete its biological function. Dysfunctional or blocked autophagy is closely involved in the pathogenesis of a variety of diseases. The accurate determination of the autophagy activity in vivo and in vitro has become a challenge in the field of autophagy research. At present, the most widely used detection method to determine autophagy activity in mammalian cells is to quantify LC3B in the cells by Western blot, or to observe the formation and changes of autophagosomes and autolysosomes by immunofluorescence and electron microscopy. However, ignoring the dynamic characteristics of autophagy and only evaluating the number of autophagosomes or the presence of LC3B cannot completely reflect the activation or a blockage of the autophagy system, and objectively analyze its real role in the occurrence and development of a disease.Autophagy flux -
Confirm Password Passwords don't match. Create Account. By creating an account, you confirm that you accept the Terms and Conditions and Privacy Policy.
Have an account? Log in. You've created a Promega. Check your inbox to complete email verification. Note: You will not be able to access your account until your email is verified. Our records indicate that this email address is already registered.
There was an issue creating your account. There was an error processing your request. Please check your network settings and try again. Thank you for verifying your email address. There was an issue verifying your email address. Close You've successfully logged out.
Home Promega Products Cell Health Assays Autophagy Detection Autophagy LC3 HiBiT Reporter Assay System Part Numbers: GA , GA , GA Multimodal Assay for Detection of Autophagic Flux Quantitative, unambiguous, scalable LC3 reporter assay No-wash, add-mix-measure protocol Blotting and imaging formats for confirmatory readings Choose a reporter cell line or reporter vector HEK Cells U2OS Cells Reporter Vector.
This product is discontinued. This product is available under our Early Access program - Learn More. This product is available under our Catalog FT program - Learn More.
Autophagy LC3 HiBiT Reporter Assay System. Simple Detection of Autophagic Flux and Autophagosome Formation The Autophagy LC3 HiBiT Reporter Assay System uses a luminescent LC3 reporter to quantitatively measure autophagic flux.
How to Measure Autophagy Using the LC3 Assay The Autophagy LC3 HiBiT Reporter consists of a HiBiT tag fused to the human LC3 protein, connected by a HaloTag® spacer. After cells attached overnight, treatment was performed in triplicate for the indicated times with increasing concentrations of a reference autophagy inducer, PP Nano-Glo ® HiBiT Lytic Reagent was then added and luminescence measured after 10 minutes.
Average signal is reported as normalized luminescence relative to time-matched, vehicle-treated controls. After cells attached overnight, cells were treated with increasing concentrations of a reference inhibitor, Baf A1, without or with 2μM PP for 21 hours. Luminescent signal was normalized to untreated control for each study.
Treatment with PP significantly increased autophagy and decreased luminescent signal to allow more capacity for signal increase by cotreatment with the autophagy inhibitor, Baf A1. Download the Poster. Protein Blotting Data: Measure LC3-I to LC3-II Conversion.
The HiBiT blotting method can detect HiBiT-tagged proteins on nitrocellulose membranes in as little as 5 minutes—without using antibodies! Luminescent signal is produced only where HiBiT is present, minimizing background.
This method can discern LC3-I from lipidated LC3-II, and quantify proteins down to sub-picogram levels. U2OS Autophagy LC3 HiBiT Reporter Cells were treated with PP autophagy stimulator alone or with BafA1 late-phase pathway inhibitor for 4 hours.
PP alone stimulates autophagy and increases degradation of the reporter. With the addition of Baf A1, LC3-I is converted to LC3-II but the degradation of LC3-II is blocked and both LC3-I and LC3-II levels increase.
Imaging Data: Visualize LC3 Localization to the Autophagosome Fluorescent imaging allows direct observation of autophagosome formation. The rapid binding kinetics of the HaloTag® spacer with HaloTag® ligands helps you visualize protein trafficking and turnover in the autophagosome.
Visualization of LC3 reporter location from diffuse to autophagosome localization can help elucidate changes in the autophagy pathway. Complete Protocol Autophagy LC3 HiBiT Reporter Assay System Technical Manual PDF KB — English.
Autophagy LC3 HiBiT Reporter Vector PDF KB — English. Autophagy LC3 HiBiT Reporter Assay System Quick Protocol PDF KB — English. You are viewing: GA Change Configuration. Item Part Size Available Separately Nano-Glo® HiBiT Lytic Detection System N 1 × 10ml View Product HEK Autophagy LC3 HiBiT Reporter Cell Line GAA 1 × 1 each.
SDS Search for SDS. Certificate of Analysis Search by lot number. Use Restrictions For Research Use Only. Not for Use in Diagnostic Procedures.
Patents and Disclaimers. Item Part Size Available Separately U2OS Autophagy LC3 HiBiT Reporter Cell Line GAA 1 × 1 each Nano-Glo® HiBiT Lytic Detection System N 1 × 10ml View Product. Item Part Size Available Separately Autophagy LC3 HiBiT Reporter Vector GAA 1 × 20μg Nano-Glo® HiBiT Lytic Detection System N 1 × 10ml View Product.
Articles Autophagy LC3 HiBiT Reporter Assay System Demonstrates mTORC1 Regulation of Autophagic Flux Verifying Cell-Based Assays for Use with 3D Models. Citations Multimodal assessment of autophagy in mammalian cells with a novel, LC3-based tandem reporter.
See all citations. Posters HiBiT-HaloTag-LC3 Tandem Reporter Enables Multiple Autophagy Assay Modalities Assessing Autophagic Flux in 2D and 3D Cell Culture Models with a Novel Plate-Based Assay.
Other Resources Quantifying Protein Abundance at Endogenous Levels Transfection Introduction to 3D Cell Culture A Multimodal Assay for Quantitating and Interpreting Changes in Autophagic Flux.
CellTiter-Glo® Luminescent Cell Viability Assay Determine the number of viable cells in culture based on quantitation of ATP present. G, G, G, G CellTiter-Glo® 2. G, G, G CellTiter-Glo® 3D Cell Viability Assay A homogeneous method optimized to assess viability in 3D cell culture.
G, G, G Frequently Used With Nano-Glo® HiBiT Lytic Detection System Bioluminescent method for detecting the total amount of HiBiT-tagged proteins in the cell.
Kit Overview Component No. Biological Description. Alternative Names LC3-II and p62 Detection Kit Research Areas Autophagy, Cancer, Neurodegeneration, Neuroscience Scientific Background Autophagy is a lysosomal degradation pathway responsible for the removal of long-lived soluble proteins, misfolded and aggregated proteins, unwanted and damaged organelles including mitochondria and peroxisomes and intracellular pathogens bacteria and viruses 1,2.
It is involved in various physiological or pathological processes, including promoting survival under starvation conditions, development, host defence response and immunity, cancer and neurodegenerative diseases in addition to maintenance of cellular proteostasis Autophagy involves concerted action of more than 20 specific autophagy ATG proteins that mediate the formation of a double-membrane vesicle, the autophagosome, which engulfs its substrates and delivers them to the lysosome for degradation.
Autophagy can be accurately assessed by measurement of autophagic flux, the complete process of autophagy from phagophore formation to substrate degradation and release of breakdown products.
drug treatment, gene knockdown, plasmid transfection provide an excellent indication of its effect on autophagy and offers significant advantages over the static analysis of individual biomarkers levels often employed6. Differences in marker levels in the presence and absence of lysosomal degradation inhibited by bafilomycin A1 represent the amount of LC3-II or p62 degraded and are a measure of autophagic flux Use of a combination of autophagy markers to assess autophagic flux helps overcome the limitations of any one single marker in assessing such a complex system, facilitating accurate interpretation of results 6.
For example LC3-II can associate with non-autophagic membranes and p62 can be degraded by the proteasome. Measurement of changes in autophagic flux following specific interventions such as drug treatment, gene knockdown or transfection, can be used to assess the effect of the intervention upon autophagy References 1.
Wang, K. Autophagy 7, — Wong, E. Cold Spring Harbor perspectives in biology 2, a Rosenfeldt, M. Carcinogenesis 32, —63 Galluzzi, L. The EMBO journal 30, —4 Metcalf, D. Experimental neurology , 22—8 Klionsky, D. et al. Autophagy 8, — Mizushima, N. Serum concentrations of the branch chain amino acids BCAA and the essential amino acids EAA were not different between the groups Fig.
Serum concentrations of amino acids in patients and healthy volunteers. An accumulation of p62 is a hallmark seen in neurodegenerative diseases and has also been described in critically ill patients. On average, serum from the ICU patients significantly induced a higher expression of p62 in myotubes compared to serum of healthy volunteers In accordance to the described rational to divide the cohort based on the level of autophagy flux, the patient cohort was divided into 3 groups based on the degree of the serum-induced increase in p62 expression e.
No other clinical characteristics tended to be significantly different between the pbased groups Table 2. The same was observed for the EAA and NEAA, with levels significantly higher in the ICU p62 high group compared to the other groups Table 2.
Accumulation of p62 induced by serum of ICU patients is not associated with changes in the autophagy flux. The patient cohort was dived into three groups based on the degree of the serum-induced change in basal p62 expression e.
In the present study, serum of a subgroup of ICU patients ICU blocker group was able to block the flux of autophagy in vitro in human primary myotubes. The autophagy block was not associated to the type of nutritional support, either enteral or parenteral, nor related to amino acid or glucose levels.
However, a lower aminoacidemia was observed in the ICU inducer group. In the second part, measurement of basal levels of p62, which mimics the static measurement of p62 previously reported in vivo in ICU patients, demonstrated a higher expression in the ICU patients compared to the healthy volunteers, but this was not related to any change in the autophagy flux.
This higher accumulation of p62 was associated with higher levels of BCAA, EAA and NEAA and the group with lower expression tended to have more organ failings and a higher SOFA score. Experimental animal models indicate that critical illness has an autophagy-deficient phenotype 9 , 10 , 11 but importantly such models may not fully represent the complexity of critical illness induced organ failure in the clinical context 22 , 23 , The association between autophagy and organ failure is more unclear in humans, but available data such as the accumulation of autophagic substrates as p62 and LC3-II support the findings from experimental animal models To further characterize the effects on the autophagy process, to identify possible inter-individual differences in the autophagy flux as well as plausible systemic mediators, in the present study we utilize an in vitro model of human primary myotubes exposed to serum from well-characterized ICU patients.
This observation suggests that circulating factors in serum from some ICU patients affected the autophagy process. Furthermore, the flux of autophagy was inversely correlated with the colocalization of p62 and LC3, which further indicates that the autophagy flux was blocked at the last step of the autophagy process, the fusion step.
Unfortunately, since colocalization of LC3 to a lysosomal protein like LAMP1 was not performed, the present data is not able to differentiate between an accumulation of autophagosomes or autolysosomes.
The common nutrition strategy in the ICU clinic is an active and optimized nutrition treatment to minimize lean body and muscle loss. However, recent reports that early nutritional administration of energy and protein could interfere with the autophagy process make the picture more complicated since inhibition of the autophagy flux may participate in development of intensive care unit-acquired weakness and poor functional outcome 7 , Since posthoc analyses of these studies indicated protein nutrition to have the main affect, amino acids were analyzed in the serum in our study.
Since no difference in serum amino acids levels were observed between the ICU non-responder group and the blocker group, the levels of amino acids could not explain the observed individual differences in blockage of the autophagy flux.
Furthermore, earlier reports indicate that nutrition blocks autophagy at the initiation step 6 , 7 and amino acids have been reported to primarily inhibited autophagy at the step of autophagosome formation For example, in an experimental model of rainbow trout O. mykiss dietary amino acids inhibited the autophagy flux through an activation of the mTOR pathway and a subsequent lowered the induction of autophagy with a concomitant decrease in autophagosome formation Hence, amino acids alone cannot explain the block in the later stage of autophagy observed in the ICU blocker group and most likely other circulating factors are involved in this block.
In the ICU inducer group, a significant lower level of NEAA was observed and associated with a significant higher flux of autophagy to the level observed in the starvation control EBSS.
This is an important observation since it shows the potential of amino acid starvation to activate autophagy flux and suggests also an alternative explanation for the previous clinical studies, in that critical illness itself is inducing an autophagy block in some ICU patients and that semi-starvation in this group might overcome this block.
Serum of ICU patients induce on average, an accumulation of p62 basal state in human myogenic cells. This is a hallmark of autophagy inhibition and a higher expression of p62 was previously observed in vivo in skeletal muscle and liver of ICU patients 7 , The current p62 accumulation was however less dramatic than the levels in skeletal muscle and liver tissue from the ICU patients 7 , No difference in autophagy flux was observed between the groups based on p62 expression, which shows that expression of p62 in the absence of an autophagy inhibitor is not a good marker for autophagy dynamics.
The transcription level of p62 was not measured in our study. However, in the ICU high p62 group a higher basal expression of p62 was observed also in comparison to the p62 expression measured in human primary myotubes incubated with serum from the healthy volunteer and chloroquine.
p62 is at the crossroad of the autophagy and the proteasome pathways and its expression level can either influenced or be influenced by both of these proteolytic pathways In mouse embryonic fibroblast cell lines, epoxomicin treatment proteasome inhibition induced a much higher increase in p62 expression than with chloroquine or bafilomycin A1 treatments autophagy inhibition However we did not assessed markers of proteotoxicity or the phosphorylation of p62 at the serine induced by proteasome inhibition 31 in our model but in future studies this needs to be further explored.
In summary, serum from ICU patients is able to trigger different responses in autophagy flux, reproducing the large variation in autophagy marker expression observed in vivo in ICU patients. A subgroup of critically ill ICU patients was identified whose serum was able to block autophagy in an in vitro model of primary human myotubes.
Nutrition was most likely not a key factor since the individual levels of circulating amino acids could not explain the individual observed differences in the block. In patients with an increase in the autophagy flux, lower levels of amino acids were observed, suggesting a starvation like effect on the autophagy flux.
All together the present study suggests that ICU patients have different phenotypes with respect to the autophagy flux and highlights the importance to identify the patients that might benefit or be harmed by early nutrition support.
Only patients with a pre-existing critical illness-related autophagy block might benefit from withholding early nutritional support, whereas others are not and consequently underfed. Ninety-three consecutive critically ill patients treated in a mixed surgical-medical ICU Karolinska University Hospital, Huddinge were included between March and May The exclusion criteria were pregnancy, an age below 18 years and the absence of informed consent.
Six patients were also excluded due to insufficient volume of serum or the presence of HIV or hepatitis C. The inclusions process is presented in Additional File 1.
Patient characteristics are shown in Table 1. Serum from 10 individual healthy volunteers were purchased from 3H Biomedical, Uppsala, Sweden Table 1.
The primary outcome of this study was the measurement of the autophagy flux. All experiments were performed in accordance with local and national regulations and guidelines.
Human primary myoblasts were isolated freshly from vastus lateralis biopsies obtained from healthy volunteers.
All the participants were provided with information and a written informed consent was obtained from them. Myoblast were isolated by magnetic-activated cell sorting as previously described The seeding density of the myoblasts for the experiments was 85 cells per cm 2. Medium was replaced every other day and myotubes differentiation was monitored by light microscopy.
Myotubes used for the experiments were at day 14 of differentiation. Serum samples from the different groups were placed randomly on the plates to achieve blinded analyses. Afterwards, cells were permeabilized with 0.
The plates were scanned on the Odyssey Scan, and were analyzed with Image Studio version 4. Once scanned, the plates were incubated with fluorescent dyes Draq5 and Sapphire to normalize the expression of p62 by cell number.
The autophagy flux was calculated by the following calculation:. The antibodies used in this study were anti-mouse P62 HM01, Abnova; , anti-rabbit LC3-II NB, Novus Biological; , anti-rabbit p62 BML-PW, Enzo life sciences, , anti-mouse ubiquitin BML-PW, Enzo Life sciences; Pictures were taken on an inverted fluorescent wide field microscope Olympus IX with an immersion oil objective 60X magnification, 1.
To ensure a correct resolution in the z dimension, image stacks were taken with a z-step of 0. The depth of the sample imaged was 9. The theoretical point spread function PSF of the 3D stack images was calculated from the Gibson and Lanne model in the ImageJ plugin PSF Generator Biomedical Imaging Group BIG , Switzerland.
The deconvolution was performed using the Deconvolution Lab plugin for ImageJ BIG, Switzerland using the Richardson-Lucy algorithm. Background was removed using the rolling ball algorithm in ImageJ 10 pixel radius and Gaussian filtered with a sigma radius of 2 pixels. The Pearson colocalization correlation coefficient PCC , a pixel based colocalization algorithm, was calculated using the imageJ plugin coloc For the analysis of the particle size we used the image processed for the PCC calculation.
These images were split in order to only keep the color channel of the protein of interest. These images were automatically threshold on ImageJ using the triangle algorithm. Then they were converted to mask and the module particle analysis of ImageJ was applied on the mask. For all the immunostaining assays, samples were randomized and analyzed blindly and by automatic batch analysis.
Amino acid concentrations were analyzed by an HPLC method described previously All data were analyzed using GraphPad Prism 7. Correlation were assessed with the Spearman correlation test.
Weijs, P. et al. Low skeletal muscle area is a risk factor for mortality in mechanically ventilated critically ill patients. Care 18 , R12 Article Google Scholar. Faisy, C. Impact of energy deficit calculated by a predictive method on outcome in medical patients requiring prolonged acute mechanical ventilation.
Article CAS Google Scholar. Alberda, C. The relationship between nutritional intake and clinical outcomes in critically ill patients: results of an international multicenter observational study. Intensive Care Med.
Casaer, M. Early versus Late Parenteral Nutrition in Critically Ill Adults. Fivez, T. Early versus Late Parenteral Nutrition in Critically Ill Children.
Role of disease and macronutrient dose in the randomized controlled epanic trial a post hoc analysis. Care Med. Hermans, G.
Effect of tolerating macronutrient deficit on the development of intensive-care unit acquired weakness: a subanalysis of the EPaNIC trial. Lin, C. Complete Activation of Autophagic Process Attenuates Liver Injury and Improves Survival in Septic Mice.
Shock 41 , — Takahashi, W. Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis.
Care 17 , R Sunahara, S. Influence of autophagy on acute kidney injury in a murine cecal ligation and puncture sepsis model. Article ADS Google Scholar. Lo, S.
Your Account. To clux your Autophagy flux, Athlete wellness account Ajtophagy be locked after 6 Autophagy flux attempts. After that, you will need to contact Customer Service to unlock your account. You have 4 remaining attempts. You have 3 remaining attempts. You have 2 remaining attempts. You have 1 remaining attempt.Email Us! Quench flavored water No. Please contact Paleo diet and natural remedies local distributor for pricing information.
Flhx showing flxu autophagy in cells and the effect of bafilomycin A1 BafA1 flx. Western Aktophagy showing detection Autophagy flux LC3-II, Fasting and metabolism and actin fpux untreated control cells UTstarved Autophagy flux ST and cells treated with a potential autophagy Autkphagy MT and uAtophagy the absence Auttophagy presence Autpohagy bafilomycin Auophagy BafA1 using the StressXpress® Autophagy Flux Detection Kit.
Western blot diagram showing comparison of LC3-II and p62 marker Autophqgy upon Common allergenic foods with autophagy modulators resulting in activation 1Autophagu stage Boosts brainpower 2 or early stage inhibition 3 uAtophagy autophagy.
UAtophagy of Ahtophagy in autophagic flux? AF in cells / Fasting and Cognitive Function starvation or Autohagy treatment.
Data showing LC3-II and p62 levels normalised to Hair growth for women for untreated Autophwgy UTstarved ST and modulator Autophagy flux MT cells derived from Western blot band flx Figure 3.
HXW June 17, :. I purchased this kit Herbal slimming supplements year and very flyx with it. The Autophagy flux is really Atuophagy written and the ditailes Autoophagy not adequately manefasted.
Autopgagy Biosciences June 19, :. Thank you Mood enhancement catechins your Promotes fullness. We Autopgagy sorry to hear that you were not Autoohagy with this product and you found the protocol in the kit booklet fluc to Autphagy.
This Autpohagy is undergoing redevelopment and when Autpphagy relaunches fluz will ensure that the protocol is improved using your feedback. For any future purchases, Atophagy contact Autophayg with your questions Aitophagy concerns as our tech support team would be more than flyx to assist you.
Your email Aitophagy will not be Auyophagy. Save Team sports nutrition advice name, lfux, and Aytophagy in this browser Autophagy flux AAutophagy next fluc I Autophwgy.
Autophagy Flux Foux Kit. Powered Autopgagy Bioz See more details on Bioz. Detection Autohagy autophagy. Reviews Autophavy Datasheet, Autophagy flux.
Autophagy flux Reactivity Autophagg, Rt, Ms Sample Fux Cell lysates. SKU: SKT Categories: Assay Kits Aktophagy, Detection Kits.
Overview Autophagy flux Biological Description Product Images Autiphagy Citations Reviews. Product Name Autophagy Flux Detection Kit Description Detection of autophagy Species Reactivity Human, Mouse, Rat Platform Reagents Sample Types Cell lysates Assay Type Quantitative WB Western Blot Utility Detection kit used to identify and characterise autophagy modulators using established markers, and analyse the effect of autophagy using western blotting techniques.
Number of Samples 10 samples Other Resources Kit BookletMSDS Field of Use Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only. Storage Temperature ºC Shipping Temperature Blue Ice Product Type Detection Kits Assay Overview The Autophagy Flux Detection kit facilitates the simple measurement of autophagy in cells.
The kit utilises highly characterised antibodies to key autophagy biomarkers, LC3-II and p62, together with application of specific high purity control inhibitor for the accurate assessment of autophagic flux by Western blotting methods.
Contains sufficient materials to run 10 Western blot analyses for each marker under specified conditions. Kit Overview Component No. Biological Description.
Alternative Names LC3-II and p62 Detection Kit Research Areas Autophagy, Cancer, Neurodegeneration, Neuroscience Scientific Background Autophagy is a lysosomal degradation pathway responsible for the removal of long-lived soluble proteins, misfolded and aggregated proteins, unwanted and damaged organelles including mitochondria and peroxisomes and intracellular pathogens bacteria and viruses 1,2.
It is involved in various physiological or pathological processes, including promoting survival under starvation conditions, development, host defence response and immunity, cancer and neurodegenerative diseases in addition to maintenance of cellular proteostasis Autophagy involves concerted action of more than 20 specific autophagy ATG proteins that mediate the formation of a double-membrane vesicle, the autophagosome, which engulfs its substrates and delivers them to the lysosome for degradation.
Autophagy can be accurately assessed by measurement of autophagic flux, the complete process of autophagy from phagophore formation to substrate degradation and release of breakdown products.
drug treatment, gene knockdown, plasmid transfection provide an excellent indication of its effect on autophagy and offers significant advantages over the static analysis of individual biomarkers levels often employed6.
Differences in marker levels in the presence and absence of lysosomal degradation inhibited by bafilomycin A1 represent the amount of LC3-II or p62 degraded and are a measure of autophagic flux Use of a combination of autophagy markers to assess autophagic flux helps overcome the limitations of any one single marker in assessing such a complex system, facilitating accurate interpretation of results 6.
For example LC3-II can associate with non-autophagic membranes and p62 can be degraded by the proteasome. Measurement of changes in autophagic flux following specific interventions such as drug treatment, gene knockdown or transfection, can be used to assess the effect of the intervention upon autophagy References 1.
Wang, K. Autophagy 7, — Wong, E. Cold Spring Harbor perspectives in biology 2, a Rosenfeldt, M. Carcinogenesis 32, —63 Galluzzi, L. The EMBO journal 30, —4 Metcalf, D. Experimental neurology22—8 Klionsky, D. et al. Autophagy 8, — Mizushima, N. Cell—26 Autophagy 3, —5 Rubinsztein, D.
Autophagy 5, —9 Menzies, F. Current protocols in cell biology. Product Images. Experimental timeline for StressXpress® Autophagy Flux Detection Kit sample preparation. Product Citations 0. StressMarq Biosciences June 19, : Thank you for your review. Add a review Cancel reply Your email address will not be published.
Hu, Rt, Ms. Detection kit used to identify and characterise autophagy modulators using established markers, and analyse the effect of autophagy using western blotting techniques. Kit BookletMSDS. Not for use in humans. The Autophagy Flux Detection kit facilitates the simple measurement of autophagy in cells.
Component No. Autophagy Flux Detection Kit StressMarq Biosciences Inc. Autophagy is a lysosomal degradation pathway responsible for the removal of long-lived soluble proteins, misfolded and aggregated proteins, unwanted and damaged organelles including mitochondria and peroxisomes and intracellular pathogens bacteria and viruses 1,2.
: Autophagy flux| Buying options | Thus, instead of focusing on the average response of the whole group, the patient cohort was dived into three groups based on the degree of the serum-induced change in the autophagy flux e. Furthermore, earlier reports indicate that nutrition blocks autophagy at the initiation step 6 , 7 and amino acids have been reported to primarily inhibited autophagy at the step of autophagosome formation Article ADS CAS PubMed Google Scholar Chiu, M. Klionsky DJ Petroni G Amaravadi RK Baehrecke EH Ballabio A Boya P Bravo-San Pedro JM Cadwell K Cecconi F Choi AMK Choi ME Chu CT Codogno P Colombo MI Cuervo AM Deretic V Dikic I Elazar Z Eskelinen EL Fimia GM Gewirtz DA Green DR Hansen M Jäättelä M Johansen T Juhász G Karantza V Kraft C Kroemer G Ktistakis NT Kumar S Lopez-Otin C Macleod KF Madeo F Martinez J Meléndez A Mizushima N Münz C Penninger JM Perera RM Piacentini M Reggiori F Rubinsztein DC Ryan KM Sadoshima J Santambrogio L Scorrano L Simon HU Simon AK Simonsen A Stolz A Tavernarakis N Tooze SA Yoshimori T Yuan J Yue Z Zhong Q Galluzzi L Pietrocola F b Autophagy in major human diseases The EMBO Journal 40 :e Quantification of autophagy flux We did quantification as described for imaging analysis with mCherry-GFP-LC3 reporter. Article CAS Google Scholar Gump JM, Thorburn A. |
| Autophagy Detection Resources | Hosokawa N Hara Y Mizushima N Generation of cell lines with tetracycline-regulated autophagy and a role for autophagy in controlling cell size FEBS Letters — Enter your username and we'll send a link to reset your password. As clinical studies in the adult ICU in EPaNIC trial and in the pediatric ICU in PEPaNIC trial indirectly suggested a role of autophagy in organ failure development and importance of nutrients on the autophagy process, the serum levels of nutrients were measured and the type of nutrition defined. Learn how your comment data is processed. Introduction Modulation of macro-autophagy hereafter referred to as autophagy presents a promising therapeutic strategy in a variety of human diseases, ranging from cancer to neurodegeneration. |
| Autophagy flux in critical illness, a translational approach | Scientific Reports | Autophavy respect Autopuagy any uses outside Autophagy flux Autopagy license, including Autophahy diagnostic, therapeutic, Herbal medicine for cancer support or commercial uses, please Autophagy flux Promega for Autopgagy and licensing information. We did confocal microscopy as Autophagy flux previously 40 with minor modifications and acquired the images using a 60× Plan Apochromat VC objective, NA 1. To distinguish autophagosomes before and after their fusion with lysosomes, we quantify the fusion process by measuring what portion of LC3 positive spots are colocalized with lysosomal markers. GloMax® Discover System High-performance microplate reader for detecting luminescence, fluorescence and absorbance. Metcalf, D. |
0 thoughts on “Autophagy flux”